{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T08:22:13Z","timestamp":1773044533640,"version":"3.50.1"},"reference-count":30,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Pharmacokinetic (PK) studies of low\u2010dose prophylaxis (LDP) of coagulation factor VIII (FVIII) in children with severe haemophilia A (SHA) are scarce.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>This study aims to investigate the PK profile of children with SHA receiving LDP of FVIII.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Paediatric patients receiving FVIII infusions (10\u00a0IU\/kg twice weekly) were included. PK profiles were estimated using the Web Accessible Population Pharmacokinetic Service for Haemophilia (WAPPS\u2010Haemo). The primary outcomes were the terminal half\u2010life (t<jats:sub>1\/2<\/jats:sub>), concentration\u2013time profile, and time to reach an FVIII level of\u00a0&lt;\u00a01%. The secondary outcome was the suggested dosing interval of FVIII prophylaxis based on the individual PK profile.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Twenty\u2010five patients were recruited; their mean age was 12.3\u00a0\u00b1\u00a03.0 years. The t<jats:sub>1\/2<\/jats:sub> differed among patients receiving LDP of FVIII twice weekly, with a median of t<jats:sub>1\/2<\/jats:sub> was 14.8 h (IQR 12.6\u201316). The median time to reach an FVIII level of\u00a0&lt;\u00a01% was 73.8 h (IQR 58.8\u201380.3). Most patients could maintain a trough level of FVIII\u00a0&gt;\u00a01% longer than 48\u00a0h. At 72\u201396\u00a0h, patients needed a second dose of FVIII infusion because the FVIII level was\u00a0&lt;\u00a01%. The suggested dosing interval of FVIII prophylaxis ranged from daily to every 96\u00a0h, depending on the individual PK profile.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our study identified inter\u2010individual differences in the PK parameters using LDP of FVIII twice weekly. The inter\u2010individual results in different dosing intervals advise the timing of LDP. Estimating individual PK parameters enables the identification of the optimal prophylaxis frequency to prevent bleedings.<\/jats:p><\/jats:sec>","DOI":"10.1111\/hae.14584","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T19:53:21Z","timestamp":1652212401000},"page":"720-725","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacokinetic profile of children with haemophilia A receiving low\u2010dose FVIII prophylaxis in Indonesia: A single centre experience"],"prefix":"10.1111","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0213-7716","authenticated-orcid":false,"given":"Fitri","family":"Primacakti","sequence":"first","affiliation":[{"name":"Paediatric Haematology\u2010Oncology Division Department of Child Health Dr. Cipto Mangunkusumo Hospital Faculty of Medicine Universitas Indonesia  Jakarta Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teny T.","family":"Sari","sequence":"additional","affiliation":[{"name":"Paediatric Haematology\u2010Oncology Division Department of Child Health Dr. Cipto Mangunkusumo Hospital Faculty of Medicine Universitas Indonesia  Jakarta Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Djajadiman","family":"Gatot","sequence":"additional","affiliation":[{"name":"Paediatric Haematology\u2010Oncology Division Department of Child Health Dr. Cipto Mangunkusumo Hospital Faculty of Medicine Universitas Indonesia  Jakarta Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikari A.","family":"Sjakti","sequence":"additional","affiliation":[{"name":"Paediatric Haematology\u2010Oncology Division Department of Child Health Dr. Cipto Mangunkusumo Hospital Faculty of Medicine Universitas Indonesia  Jakarta Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Novie A.","family":"Chozie","sequence":"additional","affiliation":[{"name":"Paediatric Haematology\u2010Oncology Division Department of Child Health Dr. Cipto Mangunkusumo Hospital Faculty of Medicine Universitas Indonesia  Jakarta Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,5,10]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2012.02909.x"},{"key":"e_1_2_8_3_1","first-page":"243","article-title":"Prophylactic treatment for hemophilia A patients: a pilot study","volume":"26","author":"Chuansumrit A","year":"1995","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12838"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2010.02348.x"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13770"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1992.tb00546.x"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2011.04214.x"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03703.x"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2008.03270.x"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2010.02370.x"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24339"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2016.1214711"},{"issue":"1","key":"e_1_2_8_14_1","first-page":"66","article-title":"Individualized prophylaxis for optimizing hemophilia care: can we apply this to both developed and developing nations?","volume":"14","author":"Poon MC","year":"2016","journal-title":"Thromb J"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12055"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.05.005"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12592"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2018.01.001"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2017.1.595"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2009.02191.x"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e3180311384"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13867"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.2196\/resprot.6558"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13182"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/ped4.12252"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020005673"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14336"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/ped4.12122"},{"key":"e_1_2_8_29_1","unstructured":"Antihemophilic Factor.Available from:https:\/\/www.koate\u2010dvi.com\/documents\/385822\/0\/Koate_DVI.pdf\/fb455459\u20105ac0\u201043d3\u2010bb48\u2010363389a7c5c3?t=1414164745000Last accessed on June 13th 2021."},{"key":"e_1_2_8_30_1","first-page":"314","article-title":"Achieving and maintaining an optimal trough level for prophylaxis in haemophilia: the past, the present and the future","volume":"12","author":"Jim\u00e9nez\u2010Yuste V","year":"2014","journal-title":"Blood Transfus"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-01-528414"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hae.14584","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/hae.14584","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hae.14584","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T08:43:15Z","timestamp":1692693795000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hae.14584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,10]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.1111\/hae.14584"],"URL":"https:\/\/doi.org\/10.1111\/hae.14584","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,10]]},"assertion":[{"value":"2021-09-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}